| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |